Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |